Brief: Coeptis Therapeutics Secures Worldwide Development & Commercialization Rights To Next-Generation Gear Cell Therapy Platform
11/03/2025 14:28
March 11 (Reuters) - Coeptis Therapeutics Holdings Inc COEP.O: COEPTIS THERAPEUTICS: SECURES WORLDWIDE DEVELOPMENT & COMMERCIALIZATION RIGHTS TO NEXT-GENERATION GEAR CELL THERAPY PLATFORM COEPTIS THERAPEUTICS: FORMED NEW MAJORITY-OWNED SUBSIDIARY, GEAR THERAPEUTICS, INC. COEPTIS THERAPEUTICS: GEAR LICENSE AGREEMENT WITH VYGEN-BIO Source text: ID:nGNX6BgshH Further company coverage: COEP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Z Squared (Delaware)
See all newsBrief: Z Squared Inc. Signs Definitive Agreement To Acquire 100% Of Paradox Data And Its Union County Campus
Brief: Z Squared, Inc. To Acquire Majority Interest In Paradox Data And Its Union County Campus, A Next-Generation Data Center Development Targeting Up To 150 MW Of Firm Power
Brief: Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement To Support Ai Infrastructure Buildout
Brief: Z Squared Appoints Jon Najarian, Pete Najarian, Marc Lopresti And Jay Zapata To Newly Formed Advisory Board
Brief: Z Squared Announces Executive Leadership Appointments To Advance Ai Infrastructure Strategy